Loratadine Market Research Report By Type (Oral, Topical), By Dosage Form (Tablets, Syrups, Creams, Gels), By Strength (5 mg, 10 mg), By Application (Seasonal Allergic Rhinitis, Chronic Urticaria) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

1.1. Market Overview

1.2. Key Findings

1.3. Market Segmentation

1.4. Competitive Landscape

1.5. Challenges and Opportunities

1.6. Future Outlook

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the study

2.2.1. Research Objective

2.2.2. Assumption

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value chain Analysis

5.2. Porter's Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. LORATADINE MARKET, BY TYPE (USD BILLION)

6.1. Oral

6.2. Topical

7. LORATADINE MARKET, BY DOSAGE FORM (USD BILLION)

7.1. Tablets

7.2. Syrups

7.3. Creams

7.4. Gels

8. LORATADINE MARKET, BY STRENGTH (USD BILLION)

8.1. 5 mg

8.2. 10 mg

9. LORATADINE MARKET, BY APPLICATION (USD BILLION)

9.1. Seasonal Allergic Rhinitis

9.2. Chronic Urticaria

10. LORATADINE MARKET, BY REGIONAL (USD BILLION)

10.1. North America

10.1.1. US

10.1.2. Canada

10.2. Europe

10.2.1. Germany

10.2.2. UK

10.2.3. France

10.2.4. Russia

10.2.5. Italy

10.2.6. Spain

10.2.7. Rest of Europe

10.3. APAC

10.3.1. China

10.3.2. India

10.3.3. Japan

10.3.4. South Korea

10.3.5. Malaysia

10.3.6. Thailand

10.3.7. Indonesia

10.3.8. Rest of APAC

10.4. South America

10.4.1. Brazil

10.4.2. Mexico

10.4.3. Argentina

10.4.4. Rest of South America

10.5. MEA

10.5.1. GCC Countries

10.5.2. South Africa

10.5.3. Rest of MEA

11. COMPETITIVE LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market share Analysis

11.4. Major Growth Strategy in the Loratadine Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Loratadine Market

11.7. Key developments and growth strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales and Operating Income

11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES

12.1. Kowa

12.1.1. Financial Overview

12.1.2. Products Offered

12.1.3. Key Developments

12.1.4. SWOT Analysis

12.1.5. Key Strategies

12.2. Eisai

12.2.1. Financial Overview

12.2.2. Products Offered

12.2.3. Key Developments

12.2.4. SWOT Analysis

12.2.5. Key Strategies

12.3. Kyowa Hakko Kirin

12.3.1. Financial Overview

12.3.2. Products Offered

12.3.3. Key Developments

12.3.4. SWOT Analysis

12.3.5. Key Strategies

12.4. GSK

12.4.1. Financial Overview

12.4.2. Products Offered

12.4.3. Key Developments

12.4.4. SWOT Analysis

12.4.5. Key Strategies

12.5. Sanofi

12.5.1. Financial Overview

12.5.2. Products Offered

12.5.3. Key Developments

12.5.4. SWOT Analysis

12.5.5. Key Strategies

12.6. Johnson Johnson

12.6.1. Financial Overview

12.6.2. Products Offered

12.6.3. Key Developments

12.6.4. SWOT Analysis

12.6.5. Key Strategies

12.7. Bayer

12.7.1. Financial Overview

12.7.2. Products Offered

12.7.3. Key Developments

12.7.4. SWOT Analysis

12.7.5. Key Strategies

12.8. Boehringer Ingelheim

12.8.1. Financial Overview

12.8.2. Products Offered

12.8.3. Key Developments

12.8.4. SWOT Analysis

12.8.5. Key Strategies

12.9. Shionogi

12.9.1. Financial Overview

12.9.2. Products Offered

12.9.3. Key Developments

12.9.4. SWOT Analysis

12.9.5. Key Strategies

12.10. McNeil Consumer Healthcare

12.10.1. Financial Overview

12.10.2. Products Offered

12.10.3. Key Developments

12.10.4. SWOT Analysis

12.10.5. Key Strategies

12.11. Merck

12.11.1. Financial Overview

12.11.2. Products Offered

12.11.3. Key Developments

12.11.4. SWOT Analysis

12.11.5. Key Strategies

12.12. Astellas Pharma

12.12.1. Financial Overview

12.12.2. Products Offered

12.12.3. Key Developments

12.12.4. SWOT Analysis

12.12.5. Key Strategies

12.13. Pfizer

12.13.1. Financial Overview

12.13.2. Products Offered

12.13.3. Key Developments

12.13.4. SWOT Analysis

12.13.5. Key Strategies

12.14. Taisho Pharmaceutical

12.14.1. Financial Overview

12.14.2. Products Offered

12.14.3. Key Developments

12.14.4. SWOT Analysis

12.14.5. Key Strategies

12.15. Novartis

12.15.1. Financial Overview

12.15.2. Products Offered

12.15.3. Key Developments

12.15.4. SWOT Analysis

12.15.5. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1. LIST OF ASSUMPTIONS

TABLE 2. NORTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 3. NORTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 4. NORTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 5. NORTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 6. NORTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 7. US LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 8. US LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 9. US LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 10. US LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 11. US LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 12. CANADA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 13. CANADA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 14. CANADA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 15. CANADA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 16. CANADA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 17. EUROPE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 18. EUROPE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 19. EUROPE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 20. EUROPE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 21. EUROPE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 22. GERMANY LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 23. GERMANY LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 24. GERMANY LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 25. GERMANY LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 26. GERMANY LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 27. UK LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 28. UK LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 29. UK LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 30. UK LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 31. UK LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 32. FRANCE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 33. FRANCE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 34. FRANCE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 35. FRANCE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 36. FRANCE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 37. RUSSIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 38. RUSSIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 39. RUSSIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 40. RUSSIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 41. RUSSIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 42. ITALY LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 43. ITALY LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 44. ITALY LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 45. ITALY LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 46. ITALY LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 47. SPAIN LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 48. SPAIN LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 49. SPAIN LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 50. SPAIN LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 51. SPAIN LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 52. REST OF EUROPE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 53. REST OF EUROPE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 54. REST OF EUROPE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 55. REST OF EUROPE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 56. REST OF EUROPE LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 57. APAC LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 58. APAC LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 59. APAC LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 60. APAC LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 61. APAC LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 62. CHINA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 63. CHINA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 64. CHINA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 65. CHINA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 66. CHINA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 67. INDIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 68. INDIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 69. INDIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 70. INDIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 71. INDIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 72. JAPAN LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 73. JAPAN LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 74. JAPAN LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 75. JAPAN LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 76. JAPAN LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 77. SOUTH KOREA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 78. SOUTH KOREA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 79. SOUTH KOREA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 80. SOUTH KOREA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 81. SOUTH KOREA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 82. MALAYSIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 83. MALAYSIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 84. MALAYSIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 85. MALAYSIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 86. MALAYSIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 87. THAILAND LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 88. THAILAND LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 89. THAILAND LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 90. THAILAND LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 91. THAILAND LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 92. INDONESIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 93. INDONESIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 94. INDONESIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 95. INDONESIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 96. INDONESIA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 97. REST OF APAC LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 98. REST OF APAC LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 99. REST OF APAC LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 100. REST OF APAC LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 101. REST OF APAC LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 102. SOUTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 103. SOUTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 104. SOUTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 105. SOUTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 106. SOUTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 107. BRAZIL LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 108. BRAZIL LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 109. BRAZIL LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 110. BRAZIL LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 111. BRAZIL LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 112. MEXICO LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 113. MEXICO LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 114. MEXICO LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 115. MEXICO LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 116. MEXICO LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 117. ARGENTINA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 118. ARGENTINA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 119. ARGENTINA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 120. ARGENTINA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 121. ARGENTINA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 122. REST OF SOUTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 123. REST OF SOUTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 124. REST OF SOUTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 125. REST OF SOUTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 126. REST OF SOUTH AMERICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 127. MEA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 128. MEA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 129. MEA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 130. MEA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 131. MEA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 132. GCC COUNTRIES LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 133. GCC COUNTRIES LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 134. GCC COUNTRIES LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 135. GCC COUNTRIES LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 136. GCC COUNTRIES LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 137. SOUTH AFRICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 138. SOUTH AFRICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 139. SOUTH AFRICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 140. SOUTH AFRICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 141. SOUTH AFRICA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 142. REST OF MEA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD BILLIONS)

TABLE 143. REST OF MEA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 144. REST OF MEA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY STRENGTH, 2019-2032 (USD BILLIONS)

TABLE 145. REST OF MEA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 146. REST OF MEA LORATADINE MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL

TABLE 148. ACQUISITION/PARTNERSHIP

LIST OF FIGURES

FIGURE 1. MARKET SYNOPSIS

FIGURE 2. NORTH AMERICA LORATADINE MARKET ANALYSIS

FIGURE 3. US LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 4. US LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 5. US LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 6. US LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 7. US LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 8. CANADA LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 9. CANADA LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 10. CANADA LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 11. CANADA LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 12. CANADA LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 13. EUROPE LORATADINE MARKET ANALYSIS

FIGURE 14. GERMANY LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 15. GERMANY LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 16. GERMANY LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 17. GERMANY LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 18. GERMANY LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 19. UK LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 20. UK LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 21. UK LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 22. UK LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 23. UK LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 24. FRANCE LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 25. FRANCE LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 26. FRANCE LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 27. FRANCE LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 28. FRANCE LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 29. RUSSIA LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 30. RUSSIA LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 31. RUSSIA LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 32. RUSSIA LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 33. RUSSIA LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 34. ITALY LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 35. ITALY LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 36. ITALY LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 37. ITALY LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 38. ITALY LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 39. SPAIN LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 40. SPAIN LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 41. SPAIN LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 42. SPAIN LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 43. SPAIN LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 44. REST OF EUROPE LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 45. REST OF EUROPE LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 46. REST OF EUROPE LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 47. REST OF EUROPE LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 48. REST OF EUROPE LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 49. APAC LORATADINE MARKET ANALYSIS

FIGURE 50. CHINA LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 51. CHINA LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 52. CHINA LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 53. CHINA LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 54. CHINA LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 55. INDIA LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 56. INDIA LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 57. INDIA LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 58. INDIA LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 59. INDIA LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 60. JAPAN LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 61. JAPAN LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 62. JAPAN LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 63. JAPAN LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 64. JAPAN LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 65. SOUTH KOREA LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 66. SOUTH KOREA LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 67. SOUTH KOREA LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 68. SOUTH KOREA LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 69. SOUTH KOREA LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 70. MALAYSIA LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 71. MALAYSIA LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 72. MALAYSIA LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 73. MALAYSIA LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 74. MALAYSIA LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 75. THAILAND LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 76. THAILAND LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 77. THAILAND LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 78. THAILAND LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 79. THAILAND LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 80. INDONESIA LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 81. INDONESIA LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 82. INDONESIA LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 83. INDONESIA LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 84. INDONESIA LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 85. REST OF APAC LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 86. REST OF APAC LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 87. REST OF APAC LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 88. REST OF APAC LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 89. REST OF APAC LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 90. SOUTH AMERICA LORATADINE MARKET ANALYSIS

FIGURE 91. BRAZIL LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 92. BRAZIL LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 93. BRAZIL LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 94. BRAZIL LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 95. BRAZIL LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 96. MEXICO LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 97. MEXICO LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 98. MEXICO LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 99. MEXICO LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 100. MEXICO LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 101. ARGENTINA LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 102. ARGENTINA LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 103. ARGENTINA LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 104. ARGENTINA LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 105. ARGENTINA LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 106. REST OF SOUTH AMERICA LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 107. REST OF SOUTH AMERICA LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 108. REST OF SOUTH AMERICA LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 109. REST OF SOUTH AMERICA LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 110. REST OF SOUTH AMERICA LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 111. MEA LORATADINE MARKET ANALYSIS

FIGURE 112. GCC COUNTRIES LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 113. GCC COUNTRIES LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 114. GCC COUNTRIES LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 115. GCC COUNTRIES LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 116. GCC COUNTRIES LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 117. SOUTH AFRICA LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 118. SOUTH AFRICA LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 119. SOUTH AFRICA LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 120. SOUTH AFRICA LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 121. SOUTH AFRICA LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 122. REST OF MEA LORATADINE MARKET ANALYSIS BY TYPE

FIGURE 123. REST OF MEA LORATADINE MARKET ANALYSIS BY DOSAGE FORM

FIGURE 124. REST OF MEA LORATADINE MARKET ANALYSIS BY STRENGTH

FIGURE 125. REST OF MEA LORATADINE MARKET ANALYSIS BY APPLICATION

FIGURE 126. REST OF MEA LORATADINE MARKET ANALYSIS BY REGIONAL

FIGURE 127. KEY BUYING CRITERIA OF LORATADINE MARKET

FIGURE 128. RESEARCH PROCESS OF MRFR

FIGURE 129. DRO ANALYSIS OF LORATADINE MARKET

FIGURE 130. DRIVERS IMPACT ANALYSIS: LORATADINE MARKET

FIGURE 131. RESTRAINTS IMPACT ANALYSIS: LORATADINE MARKET

FIGURE 132. SUPPLY / VALUE CHAIN: LORATADINE MARKET

FIGURE 133. LORATADINE MARKET, BY TYPE, 2024 (% SHARE)

FIGURE 134. LORATADINE MARKET, BY TYPE, 2019 TO 2032 (USD Billions)

FIGURE 135. LORATADINE MARKET, BY DOSAGE FORM, 2024 (% SHARE)

FIGURE 136. LORATADINE MARKET, BY DOSAGE FORM, 2019 TO 2032 (USD Billions)

FIGURE 137. LORATADINE MARKET, BY STRENGTH, 2024 (% SHARE)

FIGURE 138. LORATADINE MARKET, BY STRENGTH, 2019 TO 2032 (USD Billions)

FIGURE 139. LORATADINE MARKET, BY APPLICATION, 2024 (% SHARE)

FIGURE 140. LORATADINE MARKET, BY APPLICATION, 2019 TO 2032 (USD Billions)

FIGURE 141. LORATADINE MARKET, BY REGIONAL, 2024 (% SHARE)

FIGURE 142. LORATADINE MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)

FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS